Thomas Fitzgerald
Fortuna: 14 $ al 31/07/2026
Fortuna: 14 $ al 31/07/2026
Thomas A. Fitzgerald is Chief Financial Officer, Secretary, Director & VP at TransCode Therapeutics, Inc. since 2025.
Formerly, Mr. Fitzgerald was MD-Corporate Finance & Investment Banking Unit at Leerink Partners LLC and Chief Financial Officer at Velico Medical, Inc. from 2006 to 2018.
Education includes undergraduate studies at Stanford University and an MBA from Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/05/2026 | 3 ( 0 % ) | 14 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Director Financiero/CFO | 01/07/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Velico Medical, Inc.
Velico Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Offers proprietary technologies for blood transfusion | Director Financiero/CFO | 01/12/2018 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Velico Medical, Inc.
Velico Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Offers proprietary technologies for blood transfusion | Electronic Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes diagnostics and therapeutics for the detection and treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.